Search research articles
Contact Us
Filters
Showing results (511-520 of 596) with videos related to
Page
of 60
Sort By:
Journal of Cardiac Failure
|
September 30, 2024
Safety and Feasibility of an Implanted Inferior Vena Cava Sensor for Accurate Volume Assessment: FUTURE-HF2 Trial
Nir Uriel, Kunjan Bhatt, Rami Kahwash, et al.
Circulation
|
November 3, 2020
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety
William R Hiatt, Marc P Bonaca, Manesh R Patel, et al.
International Journal of Cardiology
|
March 7, 2018
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF
Adam S Barnett, Derek D Cyr, Shaun G Goodman, et al.
Journal of Cardiovascular Computed Tomography
|
July 18, 2024
Completeness of revascularization by FFR<sub>CT</sub> in stable angina: Association to adverse cardiovascular outcomes
Kristian Tækker Madsen, Bjarne Linde Nørgaard, Kristian Altern Øvrehus, et al.
Journal of Cardiovascular Computed Tomography
|
February 10, 2018
Incidence and predictors of lesion-specific ischemia by FFR<sub>CT</sub>: Learnings from the international ADVANCE registry
Hironori Kitabata, Jonathon Leipsic, Manesh R Patel, et al.
Heart Rhythm
|
May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
European Heart Journal
|
August 24, 2014
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
Günter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
Heart (British Cardiac Society)
|
October 23, 2021
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis
Bjarne L Nørgaard, Sara Gaur, Timothy A Fairbairn, et al.
Journal of Vascular Surgery
|
October 1, 2021
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial
Nicholas Govsyeyev, Mark R Nehler, Cecilia C Low Wang, et al.
Journal of the American College of Cardiology
|
August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy
Andre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
Page
of 60
Search research articles
Search
Showing results (511-520 of 596) with videos related to
Sort By:
Page
of 60
Journal of Cardiac Failure
|
September 30, 2024
Safety and Feasibility of an Implanted Inferior Vena Cava Sensor for Accurate Volume Assessment: FUTURE-HF2 Trial
Nir Uriel, Kunjan Bhatt, Rami Kahwash, et al.
Circulation
|
November 3, 2020
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety
William R Hiatt, Marc P Bonaca, Manesh R Patel, et al.
International Journal of Cardiology
|
March 7, 2018
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF
Adam S Barnett, Derek D Cyr, Shaun G Goodman, et al.
Journal of Cardiovascular Computed Tomography
|
July 18, 2024
Completeness of revascularization by FFR<sub>CT</sub> in stable angina: Association to adverse cardiovascular outcomes
Kristian Tækker Madsen, Bjarne Linde Nørgaard, Kristian Altern Øvrehus, et al.
Journal of Cardiovascular Computed Tomography
|
February 10, 2018
Incidence and predictors of lesion-specific ischemia by FFR<sub>CT</sub>: Learnings from the international ADVANCE registry
Hironori Kitabata, Jonathon Leipsic, Manesh R Patel, et al.
Heart Rhythm
|
May 17, 2014
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
European Heart Journal
|
August 24, 2014
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
Günter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
Heart (British Cardiac Society)
|
October 23, 2021
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis
Bjarne L Nørgaard, Sara Gaur, Timothy A Fairbairn, et al.
Journal of Vascular Surgery
|
October 1, 2021
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial
Nicholas Govsyeyev, Mark R Nehler, Cecilia C Low Wang, et al.
Journal of the American College of Cardiology
|
August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy
Andre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
Page
of 60